Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786335

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786335

COVID-19 Drug Delivery Devices

PUBLISHED:
PAGES: 277 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global COVID-19 Drug Delivery Devices Market to Reach US$1.6 Billion by 2030

The global market for COVID-19 Drug Delivery Devices estimated at US$1.6 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of -0.1% over the analysis period 2024-2030. Prefilled Syringe, one of the segments analyzed in the report, is expected to record a 0.0% CAGR and reach US$790.6 Million by the end of the analysis period. Growth in the Needle-free Injectors segment is estimated at -0.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.8 Million While China is Forecast to Grow at 0.1% CAGR

The COVID-19 Drug Delivery Devices market in the U.S. is estimated at US$445.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$276.8 Million by the year 2030 trailing a CAGR of 0.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of -0.2% and -0.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR.

Global COVID-19 Drug Delivery Devices Market - Key Trends & Drivers Summarized

How Has the Pandemic Transformed Drug Delivery? Understanding the Shift in Healthcare Priorities

The COVID-19 pandemic has reshaped the global healthcare industry, accelerating the demand for advanced drug delivery devices to ensure efficient and safe administration of antiviral treatments and vaccines. The rapid development and distribution of COVID-19 vaccines necessitated the expansion of syringe and auto-injector manufacturing, leading to unprecedented growth in the drug delivery devices market. Additionally, the surge in hospitalized COVID-19 patients required improved inhalation and nebulization therapies for managing respiratory complications. The pandemic also underscored the importance of self-administered drug delivery solutions, prompting a shift toward prefilled syringes, autoinjectors, and wearable drug delivery systems. Telemedicine integration and at-home healthcare solutions have further increased demand for smart drug delivery devices that enable remote monitoring and dosage tracking. Additionally, the rising emphasis on global pandemic preparedness has prompted governments and pharmaceutical companies to invest in scalable and efficient drug delivery infrastructure.

Which Drug Delivery Devices Have Seen the Highest Demand? Exploring Key Product Segments

The COVID-19 drug delivery devices market comprises various segments, including syringes, inhalers, autoinjectors, infusion pumps, and transdermal patches. Prefilled syringes have been one of the most critical components in vaccine administration, with manufacturers ramping up production to meet global demand. Inhalation drug delivery systems, including nebulizers and dry powder inhalers, have played a crucial role in managing COVID-19-related respiratory complications, particularly among high-risk patients. Wearable drug delivery devices, such as insulin pumps and smart injectors, have gained traction as patients seek contactless and self-administered treatment solutions. Additionally, the emergence of microneedle patches for vaccine delivery has introduced a novel alternative to traditional injections, reducing the need for cold-chain storage and improving accessibility in remote regions. The shift toward needle-free drug delivery systems has also accelerated, driven by concerns over needle-stick injuries and patient compliance.

How Is Innovation Revolutionizing COVID-19 Drug Delivery? The Role of AI, Nanotechnology & Smart Devices

The pandemic has driven a wave of technological innovations in drug delivery devices, leading to the development of more efficient, patient-friendly solutions. AI-driven inhalers equipped with real-time symptom tracking have enhanced respiratory treatment adherence, particularly for long-term COVID-19 complications. The integration of nanotechnology in drug delivery has improved the bioavailability and targeted action of COVID-19 therapeutics, minimizing side effects and optimizing treatment outcomes. Additionally, smart drug delivery devices with remote connectivity features have facilitated remote patient monitoring, reducing hospital visits and improving healthcare accessibility. The development of temperature-stable vaccine formulations, combined with needle-free delivery systems, has addressed logistical challenges associated with mass immunization campaigns. Furthermore, advancements in biopharmaceuticals have led to the creation of long-acting antiviral formulations, reducing the frequency of drug administration and enhancing treatment efficacy.

What’s Driving the Growth of the COVID-19 Drug Delivery Devices Market? Key Market Influencers Explained

The growth in the COVID-19 drug delivery devices market is driven by several factors, including increased global immunization efforts, advancements in drug delivery technology, and the expansion of self-administered treatment options. The rising investment in biopharmaceuticals has accelerated the development of next-generation drug delivery solutions, improving patient compliance and therapeutic outcomes. The expansion of e-commerce and digital healthcare platforms has also facilitated the widespread availability of self-administration drug delivery devices. Additionally, government initiatives aimed at pandemic preparedness have led to increased funding for scalable vaccine distribution and emergency medical supply chains. The shift toward personalized medicine and targeted drug delivery approaches has further strengthened market growth. As the healthcare industry continues to evolve post-pandemic, the COVID-19 drug delivery devices market is expected to expand, driven by innovation, digital integration, and enhanced global healthcare infrastructure.

SCOPE OF STUDY:

The report analyzes the COVID-19 Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Prefilled Syringe, Needle-free Injectors, Inhalers, Patches); Route of Administration (Parenteral Administration, Nasal Administration, Other Administrations); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ApiJect Systems Corp.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)
  • Bharat Biotech
  • CanSino Biologics Inc.
  • Cardinal Health
  • Croda International Plc
  • Gerresheimer AG
  • GlaxoSmithKline plc (GSK)
  • Hindustan Syringes & Medical Devices Ltd.
  • Inovio Pharmaceuticals
  • Johnson & Johnson
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30276

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • COVID-19 Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Global Vaccine Distribution Drives Demand for Efficient COVID-19 Drug Delivery Devices
    • Growing Focus on Vaccine Equity and Accessibility Expands Addressable Market for Affordable Drug Delivery Solutions
    • Innovation in Needle-Free and Non-Invasive Drug Delivery Technologies Accelerates Adoption for COVID-19 Vaccines
    • Increasing Government Support and Funding for Vaccine Rollout Programs Propels Growth in Drug Delivery Device Development
    • Technological Advancements in Microneedle Patches Strengthen the Business Case for Non-Traditional Vaccine Delivery Methods
    • The Need for Mass Immunization Drives Adoption of Scalable, High-Efficiency Drug Delivery Devices
    • Rising Preference for Self-Administration and At-Home Vaccine Delivery Solutions Expands Market Opportunities
    • Expansion of Cold Chain Logistics and Temperature-Sensitive Packaging Solutions Supports Growth in Drug Delivery Devices
    • Heightened Focus on Global Pandemic Preparedness Stimulates Innovation in Rapid Response Drug Delivery Systems
    • Regulatory Approvals for Emergency Use Authorizations (EUAs) Accelerate the Development and Distribution of COVID-19 Drug Delivery Devices
    • Consumer Trust in New Vaccine Technologies Drives Demand for Safe, Reliable Drug Delivery Mechanisms
    • Global Push for Digital Health Solutions Expands Adoption of Connected Drug Delivery Devices with IoT Integration
    • Increasing Public-Private Partnerships for Vaccine Research and Development Expands Opportunities for Drug Delivery Device Manufacturers
    • Rise in Immunocompromised Populations and Increased Health Risks Post-Pandemic Sustains Demand for Effective Drug Delivery Systems
    • Growth in Collaborative Research Between Pharma Companies and Tech Firms Drives Innovation in Delivery Device Designs
    • Push for Streamlined Healthcare Supply Chains Strengthens Market Demand for Cost-Effective Drug Delivery Solutions
    • Emergence of New Variants of COVID-19 Drives Demand for Advanced, Flexible Drug Delivery Devices to Address Evolving Therapeutic Needs
    • Increased Investment in AI and Machine Learning for Personalized Vaccine Dosing Expands Market Potential for Smart Drug Delivery Systems
    • Rising Focus on Patient Comfort and Experience Spurs Growth in Painless and Low-Discomfort Delivery Devices
    • Evolving Regulatory Landscape and Compliance Challenges in Vaccine Delivery Highlight the Need for Robust, Adaptable Drug Delivery Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World COVID-19 Drug Delivery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Prefilled Syringe by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Prefilled Syringe by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Needle-free Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Needle-free Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nasal Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Nasal Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • JAPAN
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CHINA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • EUROPE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • FRANCE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • GERMANY
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED KINGDOM
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AUSTRALIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • INDIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • LATIN AMERICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MIDDLE EAST
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AFRICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!